ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates PR Newswire
March 24, 2025AIM Vaccine's mRNA shingles vaccine got FDA clinical trial approval. Its platform has advantages, AI empowers it, and the vaccine market has great potential. -
GlaxoSmithKline's Shingrix beats expectations again in Q2 despite supply constraint
fiercepharma
July 30, 2018GlaxoSmithKline's hot shingles vaccine Shingrix has routinely beaten expectations since its U.S. rollout, and its second-quarter performance was no different.
Pharma Sources Insight January 2025
